Obesity — Genetics, Pathogenesis, Therapy

  • William C. Hsu
  • Christos S. Mantzoros

Abstract

The prevalence of obesity is increasing at alarming rates across all sociodemographic groups in industrialized and developing nations alike. Obesity poses a tremendous clinical challenge, as it contributes to significant morbidity and mortality and carries a staggering economic cost. In this chapter, we examine the current understanding of the epidemiology, etiology, pathophysiology and treatment of obesity.

Keywords

Body Mass Index Bariatric Surgery Gastric Bypass Eating Disorder Gall Bladder Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends. Int J Obes Relat Metab Disord 22: 39–47, 1998.PubMedCrossRefGoogle Scholar
  2. 2.
    Mokdad, AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The Spread of the obesity epidemic in the United States. 1991–1998. JAMA 282: 1519–22, 1999.PubMedCrossRefGoogle Scholar
  3. 3.
    Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weigh gain as a risk factor for clinical diabetes mellitus in women. Ann InternMed 122: 48 1486, 1995.Google Scholar
  4. 4.
    Allison DB, Fontaine KR, Manson JE, StevensJ, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA 282: 1530–8, 1999.PubMedCrossRefGoogle Scholar
  5. 5.
    Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 329: 1008–12, 1993.PubMedCrossRefGoogle Scholar
  6. 6.
    Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 6: 97–106, 1998.PubMedCrossRefGoogle Scholar
  7. 7.
    Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27 (4): 325–51, 1997.PubMedCrossRefGoogle Scholar
  8. 8.
    Williamson DF; Madans J; Anda RF; Kleinman JC; Kahn HS; Byers T. Recreational physical activity and ten-year weight change in a US national cohort. Int J Obes Relat Metab Disord 17: 279–86, 1993.PubMedGoogle Scholar
  9. 9.
    Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA, Byers T. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 324: 739–45, 1991.PubMedCrossRefGoogle Scholar
  10. 10.
    Allison DB, Mentore JL, Moonseong H, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686–96, 1999.PubMedGoogle Scholar
  11. 11.
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–32, 1994.PubMedCrossRefGoogle Scholar
  12. 12.
    Ahima RS, Saper CB, Flier JS, Elmquist JK. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21: 263–307, 2000.PubMedCrossRefGoogle Scholar
  13. 13.
    Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130: 671–80, 1999.PubMedCrossRefGoogle Scholar
  14. 14.
    Lowell BB, Speigelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 404: 652–60, 2000.PubMedGoogle Scholar
  15. 15.
    Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404: 661–70, 2000.PubMedGoogle Scholar
  16. 16.
    Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 409 (6818): 292–3, 2001.CrossRefGoogle Scholar
  17. 17.
    National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: the Evidence Report. Obes Res 6: 515–2095, 1998.Google Scholar
  18. 18.
    National Task Force on the prevention and treatment of obesity. Very low-calorie diets. JAMA 270: 967–74, 1993.CrossRefGoogle Scholar
  19. 19.
    Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HPF, et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The European Multicentre Orlistat Study Group. Lancet 352: 167–72, 1998.PubMedCrossRefGoogle Scholar
  20. 20.
    Hollander, P, Elbein S, Hirsch I, Kelley D, McGill J, Taylor T, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes: a randomized double-blind study. Diabetes Care 21: 1288–94, 1998.PubMedCrossRefGoogle Scholar
  21. 21.
    James WPT, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WHM, Gaal LFV. Effect of sibutramine on weight maintenance after weight loss: a randomized trial. Lancet 356: 2119–25, 2000.PubMedCrossRefGoogle Scholar
  22. 22.
    NIH Consensus Development Conference. Gastrointestinal surgery for severe obesity. Nutrition 12: 397–402, 1996.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • William C. Hsu
  • Christos S. Mantzoros

There are no affiliations available

Personalised recommendations